Sanofi Receives EU Conditional Marketing Authorization For Rezurock In Chronic GVHD

AI Briefing

• – Sanofi receives EU approval for Rezurock treatment for chronic GVHD
• – Rezurock authorized to treat adults and children with chronic GVHD
• – Treatment aims to improve quality of life for patients with chronic GVHD